US 11786508
Use of sublingual dexmedetomidine for the treatment of agitation
granted A61KA61K31/4174A61K45/06
Quick answer
US patent 11786508 (Use of sublingual dexmedetomidine for the treatment of agitation) held by BioXcel Therapeutics, Inc. expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BioXcel Therapeutics, Inc.
- Grant date
- Tue Oct 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K31/4174, A61K45/06, A61K47/10, A61K9/006